Raptor Pharmaceutical partnered with DaVita's DaVita Clinical Research (DCR) subsidiary to launch a screening program to identify patients with late-onset nephropathic cystinosis

DaVita HealthCare Partners Inc.

U.S. / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Raptor Pharmaceutical Corp.

U.S. / Small-Cap Biopharma (<$1 billion)

$883.9m on 11/01/2013 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced